These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28029568)

  • 1. Differences in levels of platelet-derived microparticles in platelet components prepared using the platelet rich plasma, buffy coat, and apheresis procedures.
    Noulsri E; Udomwinijsilp P; Lerdwana S; Chongkolwatana V; Permpikul P
    Transfus Apher Sci; 2017 Apr; 56(2):135-140. PubMed ID: 28029568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat.
    Li M; Zhao Y; Chen X; Du X; Luo Y; Li Y; Kang J; Wan L; Tang J; Fu X
    Transfusion; 2024 Feb; 64(2):367-379. PubMed ID: 38174435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.
    Singh RP; Marwaha N; Malhotra P; Dash S
    Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the platelet-rich plasma and buffy coat protocols for preparation of canine platelet concentrates.
    Hoareau GL; Jandrey KE; Burges J; Bremer D; Tablin F
    Vet Clin Pathol; 2014 Dec; 43(4):513-8. PubMed ID: 25267468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates.
    Singh S; Shams Hakimi C; Jeppsson A; Hesse C
    Transfus Apher Sci; 2017 Dec; 56(6):870-874. PubMed ID: 29126740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assessment of platelet concentrates prepared by platelet-rich plasma, buffy-coat, and apheresis methods in a tertiary care hospital in South India: A cross-sectional study.
    Toora E; Kulkarni RG; Manivannan P; Sastry AS; Basavarajegowda A; Sahoo D
    Asian J Transfus Sci; 2023; 17(2):239-245. PubMed ID: 38274963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microparticle counts in platelet-rich and platelet-free plasma, effect of centrifugation and sample-processing protocols.
    Chandler WL
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):125-32. PubMed ID: 23249614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
    Pietersz RN
    Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E; Figueiredo AC; Seghatchian J
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticle and mitochondrial release during extended storage of different types of platelet concentrates.
    Marcoux G; Duchez AC; Rousseau M; Lévesque T; Boudreau LH; Thibault L; Boilard E
    Platelets; 2017 May; 28(3):272-280. PubMed ID: 27681879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
    Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
    Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
    Procházková R; Andrýs C; Hubácková L; Krejsek J
    Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet concentrates from buffy coats: improved conditions for preparation and evaluation in routine clinical use.
    Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Marconi M; Riccardi D; Sirelson V; Pappalettera M; Sirchia G
    Transfus Sci; 1993 Jan; 14(1):41-6. PubMed ID: 10148312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Therapeutic Effect of Apheresis Platelets and Buffy Coat-Derived Platelet Concentrates.
    Wang Z; Chen X; Zhang Y; Lu H; Ren L
    Clin Lab; 2024 Aug; 70(8):. PubMed ID: 39193950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell separators.
    Keklik M; Eser B; Kaynar L; Sivgin S; Keklik E; Solmaz M; Ozturk A; Buyukoglan R; Yay M; Cetin M; Unal A
    J Clin Apher; 2015 Jun; 30(3):171-5. PubMed ID: 25230340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat-derived platelet concentrates.
    Paglia G; Sigurjónsson ÓE; Rolfsson Ó; Hansen MB; Brynjólfsson S; Gudmundsson S; Palsson BO
    Transfusion; 2015 Feb; 55(2):301-13. PubMed ID: 25156572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
    Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
    Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stored platelet concentrates produced by the platelet-rich plasma method are more resistant to apoptosis but more sensitive to activation than are platelets prepared by the buffy-coat and apheresis methods.
    Leytin V; Allen DJ; Mutlu A; Mykhaylov S; Lyubimov E; Freedman J
    Transfusion; 2009 Jul; 49(7):1493-4. PubMed ID: 19602211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.